Khan Najat sold RXRX
August 18, 2025 · Form 4 insider transaction
Khan Najat sold 36,599 shares of Recursion Pharmaceuticals, Inc. at $5.52 per share, a transaction worth $202.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
36,599
Price
$5.52
Total value
$202.2K
InsiderKhan Najat
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2025
Filing dateAugust 19, 2025
Shares owned after668,197
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units.